Mehra Uneek has filed 4 insider transactions across 2 companies since March 2025.
Most recent transaction: a grant/award of 23330 shares of BridgeBio Oncology Therapeutics, Inc. ($BBOT) on March 10, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Mehra Uneek | Chief Financial Officer | A | Common Stock | 23330 | $0.00 | 23,330.0000 | 79,988,687 | 9999.99% | 0.03% |
| March 10, 2026 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Mehra Uneek | Chief Financial Officer | A | Stock Option (Right to Buy) | 105000 | $0.00 | 105,000.0000 | 79,988,687 | 9999.99% | 0.13% |
| Aug. 26, 2025 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Mehra Uneek | Chief Financial Officer | A | Stock Option (Right to Buy) | 633570 | $0.00 | 633,570.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | 4D Molecular Therapeutics, Inc. | $FDMT | Mehra Uneek | See Remarks | A | Stock Option (Right to Buy) | 130000 | $0.00 | 130,000.0000 | 46,302,407 | 9999.99% | 0.28% |